Price movement over the last 24 hours
Adaptive Biotechnologies Corp vs GameStop Corp. — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while GameStop Corp. trades at $21.7 (market cap $9.96B). The key difference: GameStop Corp. is far larger — about 3× Adaptive Biotechnologies Corp's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, GameStop Corp. nearer its low. Which is the better fit depends on your goals.
| ADPT | GME | |
|---|---|---|
Market Cap | $3.33B | $9.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $22.37 | $27.69 |
52-Week Low | $10.24 | $19.94 |
Enterprise Value | $3.19B | $5.93B |
Trailing returns across standard periods
Latest headlines on both assets
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →